Haleon PLC (GB:HLN) has released an update.
Haleon PLC has finalized the buyback of 60.5 million shares from Pfizer Inc. for £230 million, reducing the number of shares with voting rights to 9.05 billion. The repurchase involved the cancellation of half the shares and the conversion of the remainder into treasury shares. This strategic financial move aims to enhance shareholder value and may impact shareholders’ notification requirements under the FCA’s rules.
For further insights into GB:HLN stock, check out TipRanks’ Stock Analysis page.
